Hasten Biopharmaceutic (Switzerland) AG - Hanarbe 20 mg, Tabletten | | 69936 | | 01 | | Hanarbe 20 mg | | Tabletten | | C09CA09 | | Azilsartan Medoxomil | | 08.08.2024 | | |
| Composition | azilsartanum medoxomilum 20 mg ut azilsartanum medoxomilum kalicum 21.34 mg, mannitolum, acidum fumaricum, natrii hydroxidum, hydroxypropylcellulosum, carmellosum natricum conexum, cellulosum microcristallinum, magnesii stearas, pro compresso, natrium 0.80 mg. | Packungsbestandteile | | Comprimés | | Principe actif | Concentr. |
---|
Azilsartanum Medoxomilum | 20 mg |
| | Agents auxilliaires | Concentr. |
---|
Acidum Fumaricum | | Carmellosum Natricum Conexum | | Cellulosum Microcristallinum | | Hydroxypropylcellulosum | | Magnesii Stearas | | Mannitol | | Sodium Hydroxide | | Sodium | 0.8 mg | Pro Compresso | |
|
| |
|